EVENTS:   Best Equity Short Ideas Conference Call 12 - Zach Shannon/Corto Capital Advisors & Craig Huber/Huber Research Partners & Thomas Beevers /Forensic Alpha & Ed Steele/Iron Blue Financials & Bill Campbell/Paragon Intel - 12 Nov 25   Will AI Deflate the World? Macro Lessons from Three Industrial Revolutions and China - Manoj Pradhan/Talking Heads Macro - 13 Nov 25     ROADSHOWS: Forest Products Sector Equity and Commodity Research With Expertise in Distressed Debt - Kevin Mason /ERA Research   •   London   12 - 14 Nov 25       Buyside to Buyside Forum and Expert Calls across TMT, Consumer, Healthcare and Fintech - Andrew Peters /Revelare Partners   •   London   17 - 19 Nov 25       Fundamental US Healthcare Short Ideas - Dr Elliot Favus /Favus Institutional Research   •   London   17 - 19 Nov 25      

Fortnightly Publication Highlighting Latest Insights From IRF Providers

Company Research

BAM Group (BAMNB NA) Netherlands

Industrials

the IDEA!

FY23 results were well ahead of market consensus following an impressive final quarter. Ahead of BAM's CMD, the company unveiled its main financial targets for 2024 to 2026. Besides an adjusted EBITDA margin of between 4-6%, it targets revenue of €6bn+, capital ratio of c.25% and a return to shareholders consisting of a dividend amounting to 30-50% of net income from operations (8% dividend yield) and additional cash returns via share buybacks. the IDEA! argues BAM’s mid-term financial targets are not overly ambitious and reiterates their view that the stock is significantly undervalued.

Edition: 180

- 23 February, 2024